首页 > 资讯 > 基于临床的肥胖症多学科诊疗共识(2021年版)

基于临床的肥胖症多学科诊疗共识(2021年版)

泰然健康网
2025-08-29 12:35

均声明不存在利益冲突参考文献

[1] Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002[J]. JAMA, 2004,291(23):2847-2850. DOI: 10.1001/jama.291.23.2847.

[2] Wang Y, Wang L, Qu W. New national data show alarming increase in obesity and noncommunicable chronic diseases in China[J]. Eur J Clin Nutr, 2017,71(1):149-150. DOI: 10.1038/ejcn.2016.171.

[3] Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2014,384(9945):766-781. DOI: 10.1016/s0140-6736(14)60460-8.

[4] Correction to Lancet Diabetes Endocrinol 2021; 9: 373-392[J]. Lancet Diabetes Endocrinol, 2021,9(7):e2. DOI: 10.1016/s2213-8587(21)00149-2.

[5] 王友发，孙明晓，薛宏等. 《中国肥胖预防和控制蓝皮书》解读及中国肥胖预防控制措施建议[J]. 中华预防医学杂志，2019,53(9):875-884. DOI: 10.3760/cma.j.issn.0253?9624.2019.09.003.

[6] Wang L, Zhou B, Zhao Z, et al. Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004-18[J]. Lancet, 2021,398(10294):53-63. DOI: 10.1016/s0140-6736(21)00798-4.

[7] Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020,396(10258):1223-1249. DOI: 10.1016/s0140-6736(20)30752-2.

[8] 九市儿童体格发育调查协作组，首都儿科研究所. 2005年中国九市七岁以下儿童体格发育调查[J]. 中华儿科杂志，2007,045(008):609-614. DOI: 10.3760/j.issn:0578-1310.2007.08.012.

[9] Ebbeling CB, Ludwig DS. Sugar-sweetened beverages, genetic risk, and obesity[J]. N Engl J Med, 2013,368(3):287. DOI: 10.1056/NEJMc1213563.

[10] González-Muniesa P, Mártinez-González MA, Hu FB, et al. Obesity[J]. Nat Rev Dis Primers, 2017,3:17034. DOI: 10.1038/nrdp.2017.34.

[11] Haslam DW, James WP. Obesity[J]. Lancet, 2005,366(9492):1197-1209. DOI: 10.1016/s0140-6736(05)67483-1.

[12] Nixon JP, Mavanji V, Butterick TA, et al. Sleep disorders, obesity, and aging: the role of orexin[J]. Ageing Res Rev, 2015,20:63-73. DOI: 10.1016/j.arr.2014.11.001.

[13] McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis[J]. Lancet, 2012,379(9817):721-728. DOI: 10.1016/s0140-6736(11)61516-x.

[14] Shi J, Bao G, Hong J, et al. Deciphering CT texture features of human visceral fat to evaluate metabolic disorders and surgery-induced weight loss effects[J]. EBioMedicine, 2021,69:103471. DOI: 10.1016/j.ebiom.2021.103471.

[15] Lin Z, Wenhuan Feng, Yanjun Liu, et al. Machine learning to identify metabolic subtypes of obesity: A multi-center study[J]. Frontiers in Endocrinology, 2021. DOI: 10.3389/fendo.2021.713592.

[16] Frühbeck GF, Busetto L, Dicker D, et al. The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications[J]. Obes Facts, 2019,12(2):131-136. DOI: 10.1159/000497124.

[17] Garvey WT, Mechanick JI. Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity[J]. Obesity (Silver Spring), 2020,28(3):484-492. DOI: 10.1002/oby.22727.

[18] Saarma M, Goldman A. Obesity: Receptors identified for a weight regulator[J]. Nature, 2017,550(7675):195-197. DOI: 10.1038/nature24143.

[19] Ryan DH. Guidelines for Obesity Management[J]. Endocrinol Metab Clin North Am, 2016,45(3):501-510. DOI: 10.1016/j.ecl.2016.04.003.

[20] Mechanick JI, Apovian C, Brethauer S, et al. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures-2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Associ-ation, and American Society of Anesthesiologists[J]. Obesity (Silver Spring), 2020,28(4):o1-o58. DOI: 10.1002/oby.22719.

[21] 仝小林，段娟，李敏等. 《内经》肥胖三型的科学价值及应用研究的思路与方法[J]. 江苏中医药，2009,041(002):1-3. DOI: 10.3969/j.issn.1672-397X.2009.02.001.

[22] 段娟，仝小林，冀博文等. 《内经》肥胖三型判别标准的探索与研究[J]. 中国中医基础医学杂志，2010,016(005):401-404. DOI: CNKI:SUN:ZYJC.0.2010-05-023.

[23] 曲伸，陆灏. 肥胖分类的重新思考与基于代谢的个体化诊断[J]. 中华内分泌代谢杂志，2015,(8):655-658. DOI: 10.3760/cma.j.issn.1000-6699.2015.08.001.

[24] 杨玲玲，倪诚，李英帅，等. 王琦治疗肥胖经验[J]. 2013,54(021):1811-1813. DOI: CNKI:SUN:ZZYZ.0.2013-21-004.

[25] 俞若熙，李英帅，王琦. 中医干预肥胖人群的3个问题[J]. 中华中医药杂志，2016,31(10):3901-3903.

[26] Oliveros E, Somers VK, Sochor O, et al. The concept of normal weight obesity[J]. Prog Cardiovasc Dis, 2014,56(4):426-433. DOI: 10.1016/j.pcad.2013.10.003.

[27] 王崇民. 《中国居民膳食指南科学研究报告(2021)》正式发布[J]. 食品安全导刊，2021,(7):15.

[28] Tuma PA. Dietary Guidelines 2020-2025: Update on Academy Efforts[J]. J Acad Nutr Diet, 2019,119(4):672-674. DOI: 10.1016/j.jand.2018.05.007.

[29] Rubino F, Puhl RM, Cummings DE, et al. Joint international consensus statement for ending stigma of obesity[J]. Nat Med, 2020,26(4):485-497. DOI: 10.1038/s41591-020-0803-x.

[30] Moon J, Koh G. Clinical Evidence and Mechanisms of High-Protein Diet-Induced Weight Loss[J]. J Obes Metab Syndr, 2020,29(3):166-173. DOI: 10.7570/jomes20028.

[31] Evangelista LS, Jose MM, Sallam H, et al. High-protein vs. standard-protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro-HEART trial[J]. ESC Heart Fail, 2021,8(2):1342-1348. DOI: 10.1002/ehf2.13213.

[32] Magkos F. Protein-Rich Diets for Weight Loss Maintenance[J]. Curr Obes Rep, 2020,9(3):213-218. DOI: 10.1007/s13679-020-00391-0.

[33] Paula Bricarello L, Poltronieri F, Fernandes R, et al. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on blood pressure, overweight and obesity in adolescents: A systematic review[J]. Clin Nutr ESPEN, 2018,28:1-11. DOI: 10.1016/j.clnesp.2018.09.003.

[34] Azadbakht L, Fard NR, Karimi M, et al. Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial[J]. Diabetes Care, 2011,34(1):55-57. DOI: 10.2337/dc10-0676.

[35] Soltani S, Shirani F, Chitsazi MJ, et al. The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials[J]. Obes Rev, 2016,17(5):442-454. DOI: 10.1111/obr.12391.

[36] Yang Z, Scott CA, Mao C, et al. Resistance exercise versus aerobic exercise for type 2 diabetes: a systematic review and meta-analysis[J]. Sports Med, 2014,44(4):487-499. DOI: 10.1007/s40279-013-0128-8.

[37] Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures-2019 update: cosponsored by american association of clinical endocrinologists/american college of endocrinology, the obesity society, american society for metabolic & bariatric surgery, obesity medicine association, and american society of anesthesiologists-executive summary [J]. Endocr Pract, 2019,25(12):1346-1359. DOI: 10.4158/gl-2019-0406.

[38] Tremblay MS, Carson V, Chaput JP, et al. Canadian 24-Hour Movement Guidelines for Children and Youth: An Integration of Physical Activity, Sedentary Behaviour, and Sleep[J]. Appl Physiol Nutr Metab, 2016,41(6 Suppl 3):S311-S327. DOI: 10.1139/apnm-2016-0151.

[39] Mathus-Vliegen EM. Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline[J]. Obes Facts, 2012,5(3):460-483. DOI: 10.1159/000341193.

[40] Liu R, Hong J, Xu X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention[J]. Nat Med, 2017,23(7):859-868. DOI: 10.1038/nm.4358.

[41] Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest[J]. Nature, 2006,444(7122):1027-1031. DOI: 10.1038/nature05414.

[42] Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study[J]. Nat Med, 2019,25(7):1096-1103. DOI: 10.1038/s41591-019-0495-2.

[43] Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice[J]. Science, 2013,341(6150):1241214. DOI: 10.1126/science.1241214.

[44] Sun L, Xie C, Wang G, et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin[J]. Nat Med, 2018,24(12):1919-1929. DOI: 10.1038/s41591-018-0222-4.

[45] Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota[J]. Nat Rev Gastroenterol Hepatol, 2019,16(1):35-56. DOI: 10.1038/s41575-018-0061-2.

[46] de Wit L, Luppino F, van Straten A, et al. Depression and obesity: a meta-analysis of community-based studies[J]. Psychiatry Res, 2010,178(2):230-235. DOI: 10.1016/j.psychres.2009.04.015.

[47] Gariepy G, Nitka D, Schmitz N. The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis[J]. Int J Obes (Lond), 2010,34(3):407-419. DOI: 10.1038/ijo.2009.252.

[48] Rutledge T, Groesz LM, Savu M. Psychiatric factors and weight loss patterns following gastric bypass surgery in a veteran population[J]. Obes Surg, 2011,21(1):29-35. DOI: 10.1007/s11695-009-9923-6.

[49] Claes L, Vandereycken W, Vandeputte A, et al. Personality subtypes in female pre-bariatric obese patients: do they differ in eating disorder symptoms, psychological complaints and coping behaviour？[J]. Eur Eat Disord Rev, 2013,21(1):72-77. DOI: 10.1002/erv.2188.

[50] Carr D, Friedman MA. Is obesity stigmatizing? Body weight, perceived discrimination, and psychological well-being in the United States[J]. J Health Soc Behav, 2005,46(3):244-259. DOI: 10.1177/002214650504600303.

[51] Eisenberg ME, Neumark-Sztainer D, Story M. Associations of weight-based teasing and emotional well-being among adolescents[J]. Arch Pediatr Adolesc Med, 2003,157(8):733-738. DOI: 10.1001/archpedi.157.8.733.

[52] MacLean PS, Wing RR, Davidson T, et al. NIH working group report: Innovative research to improve maintenance of weight loss[J]. Obesity (Silver Spring), 2015,23(1):7-15. DOI: 10.1002/oby.20967.

[53] Hjelmesaeth J, Rosenvinge JH, Gade H, et al. Effects of Cognitive Behavioral Therapy on Eating Behaviors, Affective Symptoms, and Weight Loss After Bariatric Surgery: a Randomized Clinical Trial[J]. Obes Surg, 2019,29(1):61-69. DOI: 10.1007/s11695-018-3471-x.

[54] Sharma M. Behavioural interventions for preventing and treating obesity in adults[J]. Obes Rev, 2007,8(5):441-449. DOI: 10.1111/j.1467-789X.2007.00351.x.

[55] Svetkey LP, Stevens VJ, Brantley PJ, et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial[J]. JAMA, 2008,299(10):1139-1148. DOI: 10.1001/jama.299.10.1139.

[56] Pearl RL, Puhl RM. The distinct effects of internalizing weight bias: An experimental study[J]. Body Image, 2016,17:38-42. DOI: 10.1016/j.bodyim.2016.02.002.

[57] Kalarchian MA, Levine MD, Arslanian SA, et al. Family-based treatment of severe pediatric obesity: randomized, controlled trial[J]. Pediatrics, 2009,124(4):1060-1068. DOI: 10.1542/peds.2008-3727.

[58] Pratt KJ, Balk EK, Ferriby M, et al. Bariatric Surgery Candidates′ Peer and Romantic Relationships and Associations with Health Behaviors[J]. Obes Surg, 2016,26(11):2764-2771. DOI: 10.1007/s11695-016-2196-y.

[59] Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity [J]. Endocr Pract, 2016,22(Suppl 3):1-203. DOI: 10.4158/ep161365.Gl.

[60] Collet TH, Dubern B, Mokrosinski J, et al. Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency[J]. Mol Metab, 2017,6(10):1321-1329. DOI: 10.1016/j.molmet.2017.06.015.

[61] Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab, 2015,100(2):342-362. DOI: 10.1210/jc.2014-3415.

[62] Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes[J]. N Engl J Med, 2016,375(4):311-322. DOI: 10.1056/NEJMoa1603827.

[63] Yu X, Xu L, Zhou Q, et al. The Efficacy and Safety of the Chinese Herbal Formula, JTTZ, for the Treatment of Type 2 Diabetes with Obesity and Hyperlipidemia: A Multicenter Randomized, Positive-Controlled, Open-Label Clinical Trial[J]. Int J Endocrinol, 2018,2018:9519231. DOI: 10.1155/2018/9519231.

[64] Zhou Q, Chang B, Chen XY, et al. Chinese herbal medicine for obesity: a randomized, double-blinded, multicenter, prospective trial[J]. Am J Chin Med, 2014,42(6):1345-1356. DOI: 10.1142/s0192415x14500840.

[65] 侯瑞芳，刘晓倩，金昕，等. 泄热化浊方治疗胃热滞脾证肥胖患者的临床研究[J]. 辽宁中医杂志，2019,46(1):65-69(01):71-75. DOI: 10.13192/j.issn.1000-1719.2019.01.023.

[66] 金昕，侯瑞芳，陶枫，等. 防风通圣散调节体重和体脂的研究进展[J]. 世界中西医结合杂志，2017,10(v.12):146-150. DOI: 10.13935/j.cnki.sjzx.171038.

[67] 曾慧妍，肖颖馥，张锦明，等. 基于中医辅助传承系统的中医药治疗单纯性肥胖方剂组方规律分析[J]. 广州中医药大学学报，2017,034(004):612-616. DOI: 10.13359/j.cnki.gzxbtcm.2017.04.033.

[68] 马兰军，李峰，李波. 决明子对肥胖大学生部分形态和生理指标干预效果的实验研究[J]. 时珍国医国药，2009,020(001):41-43. DOI: 10.3969/j.issn.1008-0805.2009.01.021.

[69] 郭姣红，李旭炯，岳嘉，等. 怀牛膝对去卵巢肥胖大鼠体重和肿瘤坏死因子-α的影响[J]. 成都医学院学报，2008,3(2):

100-102,106. DOI: 10.3969/j.issn.1674-2257.2008.02.007.

[70] Huang LH, Liu CY, Wang LY, et al. Effects of green tea extract on overweight and obese women with high levels of low density-lipoprotein-cholesterol (LDL-C): a randomised, double-blind, and cross-over placebo-controlled clinical trial[J]. BMC Complement Altern Med, 2018,18(1):294. DOI: 10.1186/s12906-018-2355-x.

[71] Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society[J]. Circulation, 2014,129(25 Suppl 2):S102-S138. DOI: 10.1161/01.cir.0000437739.71477.ee.

[72] Hubbard VS, Hall WH. Gastrointestinal Surgery for Severe Obesity[J]. Obes Surg, 1991,1(3):257-265. DOI: 10.1381/096089291765560962.

[73] Cummings DE, Cohen RV. Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery[J]. Lancet Diabetes Endocrinol, 2014,2(2):175-181. DOI: 10.1016/s2213-8587(13)70198-0.

[74] Aminian A, Chang J, Brethauer SA, et al. ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30-35 kg/m(2))[J]. Surg Obes Relat Dis, 2018,14(8):1071-1087. DOI: 10.1016/j.soard.2018.05.025.

[75] Schauer PR, Nor Hanipah Z, Rubino F. Metabolic surgery for treating type 2 diabetes mellitus: Now supported by the world′s leading diabetes organizations[J]. Cleve Clin J Med, 2017,84(7 Suppl 1):S47-S56. DOI: 10.3949/ccjm.84.s1.06.

[76] 中华医学会外科学分会甲状腺及代谢外科学组，中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 中国肥胖及2型糖尿病外科治疗指南(2019版)[J]. 中国实用外科杂志，2019,39(4):301-306. DOI: 10.19538/j.cjps.issn1005-2208.2019.04.01.

[77] Paulus GF, de Vaan LE, Verdam FJ, et al. Bariatric surgery in morbidly obese adolescents: a systematic review and meta-analysis[J]. Obes Surg, 2015,25(5):860-878. DOI: 10.1007/s11695-015-1581-2.

[78] 中华医学会外科学分会内分泌外科学组，中华医学会外科学分会腹腔镜与内镜外科学组，中华医学会外科学分会胃肠外科学组，等. 中国肥胖病外科治疗指南(2007)[J]. 中国实用外科杂志，2007,27(10):759-762. DOI: 10.3321/j.issn:1005-2208.2007.10.001.

[79] 中华医学会糖尿病学分会，中华医学会外科学分会. 手术治疗糖尿病专家共识[J]. 中华糖尿病杂志，2011,3(3):205-208. DOI: 10.3760/cma.j.issn.1674-5809.2011.03.004.

[80] Pareek M, Bhatt DL, Schiavon CA, et al. Metabolic Surgery for Hypertension in Patients With Obesity[J]. Circ Res, 2019,124(7): 1009-1024. DOI: 10.1161/circresaha.118.313320.

[81] Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery: an IDF statement for obese Type 2 diabetes[J]. Arq Bras Endocrinol Metabol, 2011,55(6):367-382. DOI: 10.1590/s0004-27302011000600003.

[82] Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis[J]. Jama, 2004,292(14):1724-1737. DOI: 10.1001/jama.292.14.1724.

[83] Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults[J]. Cochrane Database Syst Rev, 2014,(8):Cd003641. DOI: 10.1002/14651858.CD003641.pub4.

[84] 王存川. 肥胖与代谢病外科学：人民卫生出版社，2014.

[85] 中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第三版)[J]. 中华普通外科杂志，2017(9). DOI: 10.3760/cma.j.issn.1007-631X.2017.09.032.

[86] 王勇，张旭. 减重及代谢疾病病人围手术期静脉血栓栓塞症预防[J]. 中国实用外科杂志，2017,37(002):129-132. DOI: CNKI:SUN:ZGWK.0.2017-02-008.

[87] Suchartlikitwong S, Laoveeravat P, Mingbunjerdsuk T, et al. Usefulness of the ReShape intragastric balloon for obesity[J]. Proc (Bayl Univ Med Cent), 2019,32(2):192-195. DOI: 10.1080/08998280.2018.1559397.

[88] Forssell H, Norén E. A novel endoscopic weight loss therapy using gastric aspiration: results after 6 months[J]. Endoscopy, 2015,47(1):68-71. DOI: 10.1055/s-0034-1378097.

[89] Camilleri M, Toouli J, Herrera MF, et al. Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device[J]. Surgery, 2008,143(6):723-731. DOI: 10.1016/j.surg.2008.03.015.

[90] Rajagopalan H, Cherrington AD, Thompson CC, et al. Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study[J]. Diabetes Care, 2016,39(12):2254-2261. DOI: 10.2337/dc16-0383.

[91] Cherrington AD, Rajagopalan H, Maggs D, et al. Hydrothermal Duodenal Mucosal Resurfacing: Role in the Treatment of Metabolic Disease[J]. Gastrointest Endosc Clin N Am, 2017,27(2):299-311. DOI: 10.1016/j.giec.2016.12.002.

[92] Syed MI, Morar K, Shaikh A, et al. Gastric Artery Embolization Trial for the Lessening of Appetite Nonsurgically (GET LEAN): Six-Month Preliminary Data[J]. J Vasc Interv Radiol, 2016,27(10):1502-1508. DOI: 10.1016/j.jvir.2016.07.010.

[93] Ma S, Hou D, Zhang Y, et al. Trends in abdominal obesity among Chinese children and adolescents, 1993-2015[J]. J Pediatr Endocrinol Metab, 2021,34(2):163-169. DOI: 10.1515/jpem-2020-0461.

[94] Chen S, Binns CW, Zhang Y. The importance of definition in diagnosing obesity: a review of studies of children in China[J]. Asia Pac J Public Health, 2012,24(2):248-262. DOI: 10.1177/1010539512441617.

[95] 妇幼健康研究会，妇女儿童肥胖控制专业委员会，中国儿童代谢健康型肥胖定义与管理专家委员会. 中国儿童代谢健康型肥胖定义与筛查专家共识[J]. 中国妇幼健康研究，2019,30(12):1487-1490. DOI: 10.3969/j.issn.1673-5293.2019.12.001.

[96] Styne DM, Arslanian SA, Connor EL, et al. Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 2017,102(3):709-757. DOI: 10.1210/jc.2016-2573.

[97] Quattrin T, Cao Y, Paluch RA, et al. Cost-effectiveness of Family-Based Obesity Treatment[J]. Pediatrics, 2017,140(3). DOI: 10.1542/peds.2016-2755.

[98] Mead E, Atkinson G, Richter B, et al. Drug interventions for the treatment of obesity in children and adolescents[J]. Cochrane Database Syst Rev, 2016,11:CD012436. DOI: 10.1002/14651858.CD012436.

[99] Michalsky M, Reichard K, Inge T, et al. ASMBS pediatric committee best practice guidelines[J]. Surg Obes Relat Dis, 2012,8(1):1-7. DOI: 10.1016/j.soard.2011.09.009.

[100] 中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 中国儿童和青少年肥胖症外科治疗指南(2019版)[J]. 中华肥胖与代谢病电子杂志，2019,v.5(01):10-16. DOI: 10.3877/cma.j.issn.2095-9605.2019.01.001.

[101] Griggs CL, Perez NP, Jr., Goldstone RN, et al. National Trends in the Use of Metabolic and Bariatric Surgery Among Pediatric Patients With Severe Obesity[J]. JAMA Pediatr, 2018,172(12):1191-1192. DOI: 10.1001/jamapediatrics.2018.3030.

[102] Gunatilake RP, Perlow JH. Obesity and pregnancy: clinical manag-ement of the obese gravida[J]. Am J Obstet Gynecol, 2011,204(2):106-119. DOI: 10.1016/j.ajog.2010.10.002.

[103] Moos MK, Dunlop AL, Jack BW, et al. Healthier women, healthier reproductive outcomes: recommendations for the routine care of all women of reproductive age[J]. Am J Obstet Gynecol, 2008,199(6 Suppl 2):S280-S289. DOI: 10.1016/j.ajog.2008.08.060.

[104] Karmon A, Sheiner E. Pregnancy after bariatric surgery: a comprehensive review[J]. Arch Gynecol Obstet, 2008,277(5):381-388. DOI: 10.1007/s00404-008-0608-5.

[105] Global BMIMC, Di Angelantonio E, Bhupathiraju Sh N, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents[J]. Lancet, 2016,388(10046):776-786. DOI: 10.1016/s0140-6736(16)30175-1.

[106] Bosello O, Vanzo A. Obesity paradox and aging[J]. Eat Weight Disord, 2021,26(1):27-35. DOI: 10.1007/s40519-019-00815-4.

[107] 朱翠玲，曲伸. 以疾病为中心的肥胖伴2型糖尿病的联合治疗及中心化建设[J]. 中华糖尿病杂志，2020,12(10):850-853. DOI: 10.3760/cma.j.cn115791-20200203-00042